CION Cancer Clinics
Why muscle in the TURBT specimen matters | CION Cancer Clinics
The report says whether detrusor muscle was in the specimen because the most important question after a TURBT is whether the cancer has reached the muscle of the bladder wall, and the laboratory can only answer that if some muscle was in the pot. "No detrusor muscle seen" means the question is still open, not that the answer is bad. This page explains the line and what usually follows it. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
On this page
- Why does the report say whether muscle was in the specimen?
- What are the layers the pathologist is looking at?
- How does the specimen become that line on the report?
- Muscle present and muscle absent, compared
- Words around this line, in plain language
- What "no muscle seen" does and does not mean
- Three things families tell us, and what is actually true
- Common questions about muscle in the TURBT specimen
The short answer
Why does the report say whether muscle was in the specimen?
Because the single most important question after a TURBT is whether the cancer has reached the muscle of the bladder wall, and the laboratory can only answer it if some of that muscle was in the pot. "Detrusor muscle present" means the question could be answered. "No detrusor muscle seen" means it could not, whatever else the report says.
What the detrusor is
The detrusor is the muscle layer of the bladder. It is what squeezes when you pass urine. Under the lining and a thin cushion layer, it forms most of the thickness of the wall. Cancer that has grown into it behaves very differently from cancer that has not, and is treated very differently too.
Why one line changes the plan
Cancer that has not reached the muscle is usually treated by TURBT, bladder washes and check cystoscopies, keeping the bladder. Cancer that has reached the muscle is usually treated by removing the bladder or by radiotherapy with chemotherapy. The report can only put you on the right side of that line if it saw the muscle and saw whether cancer was in it.
This page explains what the line on the report means. It cannot tell you which side of the line you or your parent is on.The bladder wall
What are the layers the pathologist is looking at?
From the inside out. The stage on your report is simply the deepest layer the cancer had reached.
The lining
Called the urothelium. Most bladder cancers start here. A growth confined to this layer is stage Ta, and a flat abnormal patch here is called carcinoma in situ.
The cushion beneath
Called the lamina propria, a thin layer of connective tissue with small blood vessels. Cancer that has grown into it is stage T1. It is still called non-muscle-invasive, but it is closer to the muscle and taken more seriously.
The muscle
The detrusor. Cancer that has grown into it is stage T2, and the whole approach changes. This is the layer the surgeon deliberately scrapes into so the laboratory can check it.
The pathologist can only report on muscle that was actually in the sample.The fat and beyond
Outside the muscle sits fat, then neighbouring organs. Cancer here is stage T3 or T4. A TURBT cannot safely reach these layers, so this depth is usually judged from scans rather than from the specimen.
Not sure whether this applies to you?
Ask an oncologistIn the laboratory
How does the specimen become that line on the report?
Pots are labelled
The surgeon sends the growth and the tissue from its base in separate pots, often adding a note about where each came from. The base is where the muscle should be.
Slices become slides
The tissue is fixed, cut into very thin slices and stained. Every chip from a TURBT is examined, because a small piece can carry the deepest part.
The pathologist looks for muscle
Thick bundles of detrusor look different from the thin wisps of muscle that sit in the cushion layer. Telling the two apart is a specific skill, and it is the reason the report states it in so many words.
The depth is called
If detrusor is present, the report says whether cancer is in it. If it is absent, the report says so, and the stage carries an unspoken "as far as we can see".
Side by side
Muscle present and muscle absent, compared
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your report
Words around this line, in plain language
- Detrusor muscle / muscularis propria
- Two names for the same thing: the thick muscle of the bladder wall. Reports use either.
- Muscularis mucosae
- Thin strands of muscle inside the cushion layer. Not the detrusor. Cancer reaching these is still T1, and a careful report says which muscle it means.
- Lamina propria
- The cushion layer between lining and detrusor. Cancer here is T1, often written as "invades lamina propria".
- Under-staged
- The true depth was deeper than the first report could show, usually because the muscle was not sampled.
- Deep resection biopsy
- A separate, deliberate scrape of the base of the growth, sent in its own pot to make sure detrusor is included.
Being straight with you
What "no muscle seen" does and does not mean
It does not mean the cancer has reached the muscle. It means the laboratory could not check. Many people whose first sample had no muscle turn out, on the second look, to have cancer that never reached it. The line is a gap in the evidence, not a bad result.
Why it happens even in careful hands
A small growth on a stalk can be removed cleanly without the loop ever needing to reach the muscle. Heavy bleeding can hide the base. In some parts of the bladder the wall is so thin that scraping deeper risks going through it. And a growth sitting near the openings of the tubes from the kidneys has to be handled with care. None of these is a fault.
When it matters less
For a single, small, low grade growth of stage Ta, guidelines accept that muscle in the sample is less critical, because the chance of such a growth having reached the muscle is small. Your team may reasonably decide not to go back in. Ask them to say which group you are in and why.
What the page cannot tell you
Whether your own report needs a second look. That depends on the grade, the stage as far as it could be read, what the surgeon saw, and the scan. Bring the report to the appointment and ask directly: was muscle present, and if not, what do you want to do about it?
Commonly believed
Three things families tell us, and what is actually true
It means the opposite of a finding: nothing was checked. The muscle was not in the pot, so the pathologist could not say either way. The second TURBT exists to answer exactly this, and it often answers it with good news.
Going deeper on a wall a few millimetres thick means risking a hole in the bladder. A surgeon who stops short in a thin or bleeding area and plans a second look is making a safe choice, and that is what the guidelines describe.
It means the depth was checked. The report will then say whether cancer was found in that muscle. Muscle present with cancer in it is the finding that moves treatment to a bigger operation, so read the next sentence of the report, not just this one.
Questions we are asked
Common questions about muscle in the TURBT specimen
My father's report says "no muscularis propria identified". Is that the same thing?
Yes. Muscularis propria and detrusor muscle are two names for the same layer. The sentence means the laboratory did not find that layer in the sample, so it could not say whether the cancer had reached it. Ask the team what they plan to do about the gap.
Does this always mean a second operation?
Usually, when the cancer is high grade or T1, because the depth cannot be trusted without it. For a small, low grade Ta growth, many teams accept the report as it is and move to check cystoscopies. Which applies depends on the rest of the report, so ask rather than assume.
Can the slides be re-read to find muscle?
A second pathologist can review the same slides, and sometimes deeper cuts of the same tissue block are made. This occasionally finds muscle that was not seen at first. It cannot create muscle that was never in the pot, so if the base was not sampled, a re-read will not settle it.
Why would the surgeon not just scrape deeper?
The bladder wall is thin, and beyond the muscle lies fat and bowel. Scraping too deep can make a hole, which turns a day-case operation into a longer stay and sometimes an open repair. The surgeon judges depth in the moment, and stopping short in a risky spot is a sound decision.
Is T1 with muscle present safe?
It means the cancer reached the cushion layer but the muscle was checked and was clear. That is genuinely useful, and it keeps the bladder-preserving pathway open. T1 disease is still watched closely and usually treated with washes, and a second TURBT is often advised anyway because of the T1 finding itself.
Does the CT scan show whether muscle is involved?
Not reliably. A CT is good at showing spread outside the bladder and to lymph nodes, the small glands that drain it, but it cannot tell the layers of the wall apart well enough to stage the depth. Some centres use MRI for this. The tissue remains the standard.
Will the bladder washes wait until this is settled?
Usually a course of washes such as BCG is held until the depth is known, because washes are not the right treatment for cancer in the muscle. A single wash given straight after the operation is a different thing and may already have been given.
Who should we ask about the report?
The surgeon who did the TURBT, first. If you want a second reading of the slides, ask for the blocks to be released to another pathologist. Call the helpline if you would like a CION surgical oncologist to go through the report with you and say what they would ask next.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- Cancer Research UK — Bladder cancer: stages, types and grades
- American Cancer Society — Bladder cancer stages
- NICE — Bladder cancer: diagnosis and management (NG2)
- National Cancer Institute — Bladder Cancer Treatment (PDQ), patient version
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Holding a TURBT report you do not understand?
Send it to us and a surgical oncologist will go through it with you, including whether muscle was present and what that means for the next step. One helpline serves every CION centre.